Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.

BACKGROUND Overdose deaths involving opioid pain relievers (OPR), also known as opioid analgesics, have increased and now exceed deaths involving heroin and cocaine combined. This report describes the use and abuse of OPR by state. METHODS CDC analyzed rates of fatal OPR overdoses, nonmedical use, sales, and treatment admissions. RESULTS In 2008, drug overdoses in the United States caused 36,450 deaths. OPR were involved in 14,800 deaths (73.8%) of the 20,044 prescription drug overdose deaths. Death rates varied fivefold by state. States with lower death rates had lower rates of nonmedical use of OPR and OPR sales. During 1999--2008, overdose death rates, sales, and substance abuse treatment admissions related to OPR all increased substantially. CONCLUSIONS The epidemic of overdoses of OPR has continued to worsen. Wide variation among states in the nonmedical use of OPR and overdose rates cannot be explained by underlying demographic differences in state populations but is related to wide variations in OPR prescribing. IMPLICATIONS FOR PUBLIC HEALTH PRACTICE Health-care providers should only use OPRs in carefully screened and monitored patients when non-OPR treatments are insufficient to manage pain. Insurers and prescription drug monitoring programs can identify and take action to reduce both inappropriate and illegal prescribing. Third-party payers can limit reimbursement in ways that reduce inappropriate prescribing, discourage efforts to obtain OPR from multiple health-care providers, and improve clinical care. Changes in state laws that focus on the prescribing practices of health-care providers might reduce prescription drug abuse and overdoses while still allowing safe and effective pain treatment.

[1]  L. Paulozzi,et al.  Opioid analgesics and rates of fatal drug poisoning in the United States. , 2006, American journal of preventive medicine.

[2]  K D Kochanek,et al.  Deaths: preliminary data for 1999. , 2001, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[3]  John A. H. Lee Health: United States , 1986 .

[4]  G. Pasternak,et al.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. , 2009, The journal of pain : official journal of the American Pain Society.

[5]  Li Hui Chen,et al.  Increase in fatal poisonings involving opioid analgesics in the United States, 1999-2006. , 2009, NCHS data brief.

[6]  A. Gammaitoni,et al.  Clinical Application of Opioid Equianalgesic Data , 2003, The Clinical journal of pain.

[7]  Jiaquan Xu,et al.  Deaths: final data for 2007. , 2010, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[8]  Jiaquan Xu,et al.  Deaths: preliminary data for 2009. , 2011, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[9]  M. Forrester Ingestions of Hydrocodone, Carisoprodol, and Alprazolam in Combination Reported to Texas Poison Centers , 2011, Journal of addictive diseases.

[10]  Leonard J Paulozzi,et al.  Patterns of abuse among unintentional pharmaceutical overdose fatalities. , 2008, JAMA.

[11]  Yongli Xi,et al.  Recent changes in drug poisoning mortality in the United States by urban–rural status and by drug type , 2008, Pharmacoepidemiology and drug safety.

[12]  B. Kuehn Efforts aim to curb opioid deaths, injuries. , 2009, JAMA.